Analysis and Commentary STEVEN GROSSMAN 6/4/21 Analysis and Commentary STEVEN GROSSMAN 6/4/21 President's Budget Request Confirmed for FY 22 Read More Advocacy at a Glance STEVEN GROSSMAN 2/5/21 Advocacy at a Glance STEVEN GROSSMAN 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More Analysis and Commentary STEVEN GROSSMAN 8/1/20 Analysis and Commentary STEVEN GROSSMAN 8/1/20 About the Alliance for a Stronger FDA Read More Analysis and Commentary STEVEN GROSSMAN 3/5/20 Analysis and Commentary STEVEN GROSSMAN 3/5/20 Additional funding for FDA; more Qs and As Read More Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate Read More Analysis and Commentary STEVEN GROSSMAN 2/27/20 Analysis and Commentary STEVEN GROSSMAN 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation Read More Analysis and Commentary STEVEN GROSSMAN 4/12/19 Analysis and Commentary STEVEN GROSSMAN 4/12/19 FY 20: The "Ask"; the Possible; and the Realities Read More Analysis and Commentary STEVEN GROSSMAN 6/8/18 Analysis and Commentary STEVEN GROSSMAN 6/8/18 FY 19 Appropriations the Alliance Seeks to Support Read More Advocacy at a Glance STEVEN GROSSMAN 5/4/18 Advocacy at a Glance STEVEN GROSSMAN 5/4/18 Congress Returns May 7; Starts 11-Week Sprint to August Recess and more Read More Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Alliance Announces Its FY 19 Request; Tells Congress that FDA Needs More Support and more Read More Advocacy at a Glance STEVEN GROSSMAN 3/17/17 Advocacy at a Glance STEVEN GROSSMAN 3/17/17 Alliance Responds to the President’s Proposals and more Read More Analysis and Commentary STEVEN GROSSMAN 2/19/16 Analysis and Commentary STEVEN GROSSMAN 2/19/16 Alliance Seeks $2.85 Billion for FDA for FY 17 Read More
Analysis and Commentary STEVEN GROSSMAN 6/4/21 Analysis and Commentary STEVEN GROSSMAN 6/4/21 President's Budget Request Confirmed for FY 22 Read More
Advocacy at a Glance STEVEN GROSSMAN 2/5/21 Advocacy at a Glance STEVEN GROSSMAN 2/5/21 The Senate has announced committee assignments. Senator Merkley will chair the Ag/FDA Appropriations Subcommittee and Senator Hoeven will be the Ranking Member. Read More
Analysis and Commentary STEVEN GROSSMAN 8/1/20 Analysis and Commentary STEVEN GROSSMAN 8/1/20 About the Alliance for a Stronger FDA Read More
Analysis and Commentary STEVEN GROSSMAN 3/5/20 Analysis and Commentary STEVEN GROSSMAN 3/5/20 Additional funding for FDA; more Qs and As Read More
Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Advocacy at a Glance STEVEN GROSSMAN 3/6/20 Alliance Hill Day On March 18; You Don’t Have to Be an FDA Expert to Participate Read More
Analysis and Commentary STEVEN GROSSMAN 2/27/20 Analysis and Commentary STEVEN GROSSMAN 2/27/20 More Qs and As About the FY 21 Appropriation Process Read More
Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Advocacy at a Glance STEVEN GROSSMAN 2/21/20 Alliance FY 21 “Ask” Set at $120 million above the FY 20 BA Appropriation Read More
Analysis and Commentary STEVEN GROSSMAN 4/12/19 Analysis and Commentary STEVEN GROSSMAN 4/12/19 FY 20: The "Ask"; the Possible; and the Realities Read More
Analysis and Commentary STEVEN GROSSMAN 6/8/18 Analysis and Commentary STEVEN GROSSMAN 6/8/18 FY 19 Appropriations the Alliance Seeks to Support Read More
Advocacy at a Glance STEVEN GROSSMAN 5/4/18 Advocacy at a Glance STEVEN GROSSMAN 5/4/18 Congress Returns May 7; Starts 11-Week Sprint to August Recess and more Read More
Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Alliance Announces Its FY 19 Request; Tells Congress that FDA Needs More Support and more Read More
Advocacy at a Glance STEVEN GROSSMAN 3/17/17 Advocacy at a Glance STEVEN GROSSMAN 3/17/17 Alliance Responds to the President’s Proposals and more Read More
Analysis and Commentary STEVEN GROSSMAN 2/19/16 Analysis and Commentary STEVEN GROSSMAN 2/19/16 Alliance Seeks $2.85 Billion for FDA for FY 17 Read More
